US Broker Ratings

Evolent Health, Inc (EVH) Stock Analysis: A Deep Dive into Its 84% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) is an intriguing player in the healthcare sector, specifically within the health information services industry. Headquartered in Arlington, Virginia, the company specializes in providing specialty..

Opko Health, Inc. (OPK) Stock Analysis: A Look at the 200% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a diversified healthcare company, stands out in the healthcare sector with its dual focus on diagnostics and pharmaceuticals. Headquartered in Miami, Florida, Opko operates across..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 19% Upside Potential

Investors eyeing the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing option, as the company offers a compelling blend of robust growth prospects and a significant potential..

Harrow, Inc. (HROW): Analyst Ratings Signal Strong Buy with 80% Upside Potential

Harrow, Inc. (NASDAQ: HROW), a key player in the ophthalmic pharmaceutical sector, has been gaining traction among investors due to its robust growth potential and promising analyst ratings. Headquartered in..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 40% Upside Potential for Innovators in Cell Therapy

For investors seeking exposure to the dynamic healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents a fascinating opportunity. With a market capitalization of $1.06 billion, this Bothell, Washington-based company stands..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook on a 22.68% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), headquartered in Atlanta, Georgia, stands as a prominent player in the healthcare sector, focusing on providing diversified home care services across the United States...

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating a 20% Potential Upside for Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook on a Biotech with a 22.85% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is drawing significant attention from investors, particularly those with an interest in the healthcare sector. This Canadian biotechnology company, with a market capitalization of $1.1..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 99% Potential Upside Amidst Analyst Optimism

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a key player in the biotechnology sector, is capturing investor attention with its promise of significant upside potential. Despite some challenging financial figures, the company’s..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 165% Potential Upside in the Biotech Space

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is making waves in the biotechnology sector with a market capitalization of $1.54 billion. Based in Boulder, Colorado, this innovative biopharmaceutical company is focused on..

MannKind Corporation (MNKD) Stock Analysis: Evaluating a Potential 154.97% Upside

MannKind Corporation (NASDAQ: MNKD) stands out in the healthcare sector as a biotechnology company with a targeted focus on endocrine and orphan lung diseases. With a market capitalization of $1.16..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 42.59% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) offers investors a unique opportunity within the healthcare sector, specifically in the health information services industry. With a market capitalization of approximately $1.58 billion, the..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 130% Potential Upside

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a promising player in the biotechnology sector, is capturing investor attention with its remarkable potential upside of 130.76%. This precision medicine oncology company, based in..

Zai Lab Limited (ZLAB): An Investor’s Insight into Potential 36% Upside in Biotech Innovation

In the dynamic world of biotechnology, Zai Lab Limited (NASDAQ: ZLAB) emerges as a compelling player with a promising portfolio and significant market presence. Based in Shanghai, China, Zai Lab..

Integra LifeSciences Holdings (IART) Stock Analysis: Exploring a 30% Potential Upside Amidst Healthcare Innovation

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a pivotal player in the healthcare sector, specializes in medical devices catering to neurosurgery, neurocritical care, and wound treatment. With a market capitalization of..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 128.86% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors in the healthcare sector, particularly within the specialized niche of vaccine development. With its focus on innovative immunization solutions,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unlocking a 17.98% Upside in the Healthcare Sector

Investors looking to capitalize on the robust growth within the healthcare sector should consider The Pennant Group, Inc. (NASDAQ: PNTG). This burgeoning company, with a market capitalization of $981.68 million,..

Phreesia, Inc. (PHR) Investor Outlook: A 21.94% Upside Potential in Healthcare SaaS

Phreesia, Inc. (PHR) stands at the forefront of the Health Information Services industry, delivering a robust Software-as-a-Service (SaaS) platform that significantly enhances patient engagement and streamlines operations for healthcare providers...

Enovis Corporation (ENOV) Stock Analysis: Exploring a 75% Potential Upside in the Medical Device Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of over 75%. With a market capitalization of $1.84 billion,..

Amneal Pharmaceuticals (AMRX) Stock Analysis: Unpacking a 44.88% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is making waves in the healthcare sector with a compelling potential upside of 44.88%, according to current analyst ratings. For investors seeking exposure to the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds